NDC product
Mucinex Fast-Max Cold and Flu
NDC 63824-514 · Reckitt Benckiser LLC
Key facts
| Product NDC | 63824-514 |
|---|---|
| Proprietary name | Mucinex Fast-Max |
| Nonproprietary name | Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
| Substances | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Reckitt Benckiser LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA] and 3 more |
| Marketing start | Aug 1, 2018 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: